Verax Biomedical raises $2.8M
Verax Biomedical, which has developed a test for the detection of bacterial contamination in platelets, has raised $2.8 million in debt financing [1] out of a $5 million offering, according to federal filings.
Verax Biomedical, which has developed a test for the detection of bacterial contamination in platelets, has raised $2.8 million in debt financing [1] out of a $5 million offering, according to federal filings.
Links:
[1] http://www.sec.gov/Archives/edgar/data/1161304/000155133312000019/xslFormDX01/primary_doc.xml